Literature DB >> 14722802

Ethical issues in dysphagia: when patients refuse assessment or treatment.

Helen M Sharp1, Karen N Bryant.   

Abstract

The primary goal of intervention for patients with dysphagia is to restore oral feeding. When patients are unable to achieve adequate nutrition, hydration, or safety with oral feeding, then nonoral approaches are often recommended. Although patients' rights to accept or refuse clinical recommendations are widely recognized, when a patient refuses tube feeding or other recommendations, dysphagia specialists are left with a host of practical questions about their role in caring for the patient. We review the criteria for assessing patients' capacity to make informed choices, approaches to decision making when patients lack capacity, and the roles and responsibilities of clinicians when patients choose high-risk treatment options.

Entities:  

Keywords:  Professional Patient Relationship

Mesh:

Year:  2003        PMID: 14722802     DOI: 10.1055/s-2004-815578

Source DB:  PubMed          Journal:  Semin Speech Lang        ISSN: 0734-0478            Impact factor:   1.761


  3 in total

1.  Promoting shared decision-making in rehabilitation: development of a framework for situations when patients with Dysphagia refuse diet modification recommended by the treating team.

Authors:  Franceen Kaizer; Anna-Maria Spiridigliozzi; Matthew R Hunt
Journal:  Dysphagia       Date:  2011-05-01       Impact factor: 3.438

2.  Patient refusal of thrombolytic therapy for suspected acute ischemic stroke.

Authors:  F S Vahidy; M H Rahbar; A P Lal; J C Grotta; S I Savitz
Journal:  Int J Stroke       Date:  2012-12-11       Impact factor: 5.266

3.  Legal medicine implications in fibrinolytic therapy of acute ischemic stroke.

Authors:  Monica Sabau; Simona Bungau; Camelia Liana Buhas; Gheorghe Carp; Lucia-Georgeta Daina; Claudia Teodora Judea-Pusta; Bogdan Adrian Buhas; Claudia Maria Jurca; Cristian Marius Daina; Delia Mirela Tit
Journal:  BMC Med Ethics       Date:  2019-10-14       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.